A detailed history of Mutual Of America Capital Management LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 2,776 shares of LGND stock, worth $287,815. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,776
Previous 2,824 1.7%
Holding current value
$287,815
Previous $206,000 13.11%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$68.53 - $87.91 $3,289 - $4,219
-48 Reduced 1.7%
2,776 $233,000
Q1 2024

May 02, 2024

SELL
$68.64 - $89.2 $3,088 - $4,014
-45 Reduced 1.57%
2,824 $206,000
Q4 2023

Jan 26, 2024

BUY
$49.57 - $72.63 $142,216 - $208,375
2,869 New
2,869 $204,000
Q2 2023

Aug 11, 2023

SELL
$69.53 - $79.33 $6,813 - $7,774
-98 Reduced 2.97%
3,206 $231,000
Q1 2023

May 04, 2023

SELL
$65.67 - $77.08 $3,940 - $4,624
-60 Reduced 1.78%
3,304 $243,000
Q4 2022

Feb 10, 2023

BUY
$61.72 - $96.74 $10,677 - $16,736
173 Added 5.42%
3,364 $224,000
Q3 2022

Nov 08, 2022

BUY
$0.01 - $107.56 $3 - $38,614
359 Added 12.68%
3,191 $275,000
Q2 2022

Aug 10, 2022

BUY
$74.52 - $117.06 $31,671 - $49,750
425 Added 17.66%
2,832 $253,000
Q1 2022

May 02, 2022

BUY
$94.99 - $151.56 $11,683 - $18,641
123 Added 5.39%
2,407 $271,000
Q4 2021

Feb 03, 2022

BUY
$127.69 - $165.85 $7,661 - $9,951
60 Added 2.7%
2,284 $353,000
Q3 2021

Nov 10, 2021

SELL
$102.33 - $144.73 $1.27 Million - $1.8 Million
-12,414 Reduced 84.81%
2,224 $310,000
Q2 2021

Aug 06, 2021

SELL
$113.03 - $155.64 $22,492 - $30,972
-199 Reduced 1.34%
14,638 $1.92 Million
Q1 2021

May 13, 2021

SELL
$99.52 - $215.83 $33,538 - $72,734
-337 Reduced 2.22%
14,837 $2.26 Million
Q4 2020

Feb 12, 2021

BUY
$80.55 - $106.05 $4,510 - $5,938
56 Added 0.37%
15,174 $1.51 Million
Q3 2020

Nov 13, 2020

BUY
$89.56 - $126.72 $17,822 - $25,217
199 Added 1.33%
15,118 $1.44 Million
Q2 2020

Aug 06, 2020

SELL
$68.28 - $123.65 $28,131 - $50,943
-412 Reduced 2.69%
14,919 $1.67 Million
Q1 2020

May 11, 2020

SELL
$63.37 - $107.88 $49,618 - $84,470
-783 Reduced 4.86%
15,331 $1.12 Million
Q4 2019

Feb 11, 2020

SELL
$96.94 - $113.59 $84,628 - $99,164
-873 Reduced 5.14%
16,114 $1.68 Million
Q3 2019

Nov 14, 2019

SELL
$86.25 - $120.16 $30,360 - $42,296
-352 Reduced 2.03%
16,987 $1.69 Million
Q2 2019

Aug 12, 2019

SELL
$107.38 - $129.34 $67,649 - $81,484
-630 Reduced 3.51%
17,339 $1.98 Million
Q1 2019

May 13, 2019

SELL
$105.93 - $142.47 $87,921 - $118,250
-830 Reduced 4.42%
17,969 $2.26 Million
Q4 2018

Feb 12, 2019

BUY
$128.36 - $272.13 $2.36 Million - $5.01 Million
18,398 Added 4588.03%
18,799 $2.55 Million
Q3 2018

Nov 13, 2018

BUY
$211.18 - $274.49 $68,211 - $88,660
323 Added 414.1%
401 $110,000
Q2 2018

Aug 09, 2018

BUY
$150.77 - $207.98 $11,760 - $16,222
78 New
78 $16,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.75B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.